Czech National Bank Illumina, Inc. Transaction History

Czech National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$127.73 - $147.2 $16,477 - $18,988	129 Added 0.46%	27,941 $3.84 Million
Q4 2023 Jan 08, 2024	BUY	$92.79 - $142.53 $13,361 - $20,524	144 Added 0.52%	27,812 $3.87 Million
Q3 2023 Oct 19, 2023	BUY	$128.91 - $192.44 $1.15 Million - $1.72 Million	8,953 Added 47.84%	27,668 $3.8 Million
Q2 2023 Jul 11, 2023	BUY	$183.43 - $232.67 $33,751 - $42,811	184 Added 0.99%	18,715 $3.51 Million
Q1 2023 Apr 17, 2023	BUY	$193.75 - $232.55 $25,575 - $30,696	132 Added 0.72%	18,531 $4.31 Million
Q4 2022 Jan 18, 2023	BUY	$187.24 - $242.74 $27,149 - $35,197	145 Added 0.79%	18,399 $0
Q3 2022 Oct 31, 2022	BUY	$177.23 - $227.44 $3.24 Million - $4.15 Million	18,254 New	18,254 $3.48 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

Stay updated on Czech National Bank with notifications on news.